Pakfetrat Maryam, Nikoo Mohamad Hosein, Malekmakan Leila, Tabande Mahmood, Roozbeh Jamshid, Ganbar Ali Raiss Jalali, Khajehdehi Parviz
Department of Internal Medicine, Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Hemodial Int. 2010 Oct;14(4):387-92. doi: 10.1111/j.1542-4758.2010.00469.x. Epub 2010 Aug 27.
Although it is well known that diabetics are at a higher risk of contrast-induced acute kidney injury (CI-AKI) than nondiabetic patients, the reason for this discrepancy is not well known. Thus, in this study, we compared the predisposing factors for CI-AKI between patients with and without diabetes. We prospectively studied 290 consecutive in-hospital patients including 88 diabetics undergoing coronary angiography or a percutaneous coronary intervention in Kowsar hospital, and we compared risk factors for CI-AKI between diabetic and nondiabetic patients. CI-AKI was defined as RIFLE criteria within 48 hours after contrast exposure. The incidence of CR-AKI was significantly higher in diabetic patients compared with nondiabetics (P<0.05). The incidence of CI-AKI was significantly higher in patients with diabetes and left-ventricular ejection fraction ≤40%, hypercholesterolemia, serum creatinine ≥1.1 mg/dL, estimated glomerular filtration rate (eGFR) <90 mL/min, Contrast volume ≥80 (mL), maximum safe contrast volume factor of 1.5, and dehydration, while in nondiabetics, a significantly higher incidence of CR-AKI was observed in those with serum creatinine ≥1.1 mg/dL (P=0.02) and/or eGFR<60 mL/min (P=0.01). Multiple logistic regression analysis showed hyperchlosteremia to be the strongest predictor of AKI (P=0.01, B:14.5) in diabetics, followed by eGFR<90 (P=0.05, B:12.4) but, in nondiabetics, only eGFR<60 predicted the occurrence of CI-AKI (P=0.04, B:2.3). It seems that the predisposing factors to CI-AKI differ in diabetics and nondiabetics. In patients with diabetes, hypercholesterolemia is the strongest predictor of CI-AKI, followed by eGFR and diabetics are at risk for CI-AKI in the early stage of chronic kidney disease (stage 2), accounting for the higher incidence of CI-AKI in them.
虽然众所周知,糖尿病患者发生对比剂诱导的急性肾损伤(CI-AKI)的风险高于非糖尿病患者,但这种差异的原因尚不清楚。因此,在本研究中,我们比较了糖尿病患者和非糖尿病患者发生CI-AKI的易感因素。我们前瞻性地研究了290例连续住院患者,其中包括88例在Kowsar医院接受冠状动脉造影或经皮冠状动脉介入治疗的糖尿病患者,并比较了糖尿病患者和非糖尿病患者发生CI-AKI的危险因素。CI-AKI定义为对比剂暴露后48小时内符合RIFLE标准。与非糖尿病患者相比,糖尿病患者中CR-AKI的发生率显著更高(P<0.05)。糖尿病且左心室射血分数≤40%、高胆固醇血症、血清肌酐≥1.1 mg/dL、估计肾小球滤过率(eGFR)<90 mL/min、对比剂用量≥80(mL)、最大安全对比剂用量系数为1.5以及脱水的患者中CI-AKI的发生率显著更高,而在非糖尿病患者中,血清肌酐≥1.1 mg/dL(P=0.02)和/或eGFR<60 mL/min(P=0.01)的患者中CR-AKI的发生率显著更高。多因素logistic回归分析显示,高胆固醇血症是糖尿病患者发生AKI的最强预测因素(P=0.01,B:14.5),其次是eGFR<90(P=0.05,B:12.4),但在非糖尿病患者中,只有eGFR<60可预测CI-AKI的发生(P=0.04,B:2.3)。似乎糖尿病患者和非糖尿病患者发生CI-AKI的易感因素不同。在糖尿病患者中,高胆固醇血症是CI-AKI的最强预测因素,其次是eGFR,并且糖尿病患者在慢性肾脏病早期(2期)就有发生CI-AKI的风险,这解释了他们中CI-AKI发生率较高的原因。